- Home
- FFIC vs VOR Comparison
FFIC vs VOR Comparison
Compare FFIC & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFIC | VOR |
|---|---|---|
| Founded | 1929 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.1M | 562.6M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FFIC | VOR |
|---|---|---|
| Price | $14.96 | $13.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $16.80 | ★ $64.78 |
| AVG Volume (30 Days) | 175.2K | ★ 544.3K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.85% | N/A |
| EPS Growth | ★ 151.43 | 2.86 |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $7,455,000.00 | N/A |
| Revenue This Year | $14.57 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $27.74 | ★ N/A |
| Revenue Growth | ★ 7.31 | N/A |
| 52 Week Low | $10.65 | $0.13 |
| 52 Week High | $17.79 | $49.95 |
Technical Indicators
Market Signals| Indicator | FFIC | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 35.58 | 45.09 |
| Support Level | $14.44 | $11.76 |
| Resistance Level | $15.57 | $14.73 |
| Average True Range (ATR) | 0.40 | 1.02 |
| MACD | -0.09 | -0.22 |
| Stochastic Oscillator | 6.36 | 15.88 |
Price Performance
Historical ComparisonAbout FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.